Coronavirus may not just be a respiratory disease but could also be a blood vessel disease, doctors have suggested, which could help explain why COVID-19 patients have experienced heart attacks, blood clots, and other ranging symptoms – and may also suggest that the disease is currently being treated the wrong way.
No harm of RAAS inhibitors in COVID - Potential benefit with ACE Inhibitors and Statins? Do these hypothesis generating findings once again point to the Vascular Disease in COVID-19?— Mandeep R. Mehra, MD (@MRMehraMD) May 1, 2020
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/hxE701qvd5
Implications: ventilators not enough
A doctor inspects a ventilator. (File photo: AFP)
Why is Covid-19 so different from other viruses? How can you protect yourself from the virus? What is needed to defeat Covid-19? I dive into all of this on my podcast episode with The Health Hub "Covid-19 - What We Know. What We Need To Know." https://t.co/2lE5xIp1L0 pic.twitter.com/QuHoe3jaGB— William Li (@drwilliamli) May 15, 2020
Implications: statins, ACE blockers could work as treatment
Data on 8910 patients hospitalized with a diagnosis of #COVID19 were analyzed. Neither the use of angiotensin-converting–enzyme inhibitors nor the use of angiotensin-receptor blockers was associated with an increased risk of in-hospital death.— NEJM (@NEJM) May 1, 2020